HERA Advisory Forum
This group brings together Commission’s Department for Health Emergency Preparedness and Response (HERA) and technically competent bodies in the Member States.
It serves as a platform to exchange information and discuss ideas linked to HERA’s activities as well as be a space for Member States to share their views. The HERA Advisory Forum was established by Commission Decision C(2021) 6712.
The Forum also serves as a connection between members to facilitate the exchange of views. The topics for discussion, especially supply chains and manufacturing of medical countermeasures as well as epidemiological intelligence and surveillance are sensitive issues. The HERA Advisory Forum has 2 sub-groups, the Civil Society Forum and the Joint Industrial Cooperation Forum.
Civil Society Forum
This sub-group helps ensure that the HERA Advisory Forum receives regular input, views and opinions from civil society stakeholders. Along with the Joint Industrial Cooperation Forum, it provides the Advisory Forum with observations and assessments from a diverse range of stakeholders. This supports the work of the Advisory Forum and contribute to its informed opinions and conclusions.
The Civil Society Forum makes the interactions between interested parties easier and act as a contact point between HERA and stakeholders representing patients, consumers and healthcare professionals. It provides views, observations and opinions from civil society stakeholders to the HERA Advisory Forum on matters of health preparedness and response, with a focus on medical countermeasures.
Finally, the Forum monitors and gives its views on research, industrial and policy developments in in areas relevant to HERA’s activities.
Joint Industrial Cooperation Forum
The Joint Industrial Cooperation Forum (JICF) is set up as a subgroup of HERA’s Advisory Forum to support collaboration with health-related industrial ecosystems in the area of preparedness and response to health crises. Along with the Civil Society Forum, it provides HERA’s Advisory Forum with observations and opinions from a diverse range of interested parties.
Its mandate is to identify and, where possible, reduce congestions within and outside the EU, including market failures and supply chain dependencies that could limit the production capabilities of relevant medical countermeasures and their raw materials.
The Forum enables HERA to closely follow-up what is happening across critical supply chains in order to identify and take the appropriate actions in partnership with the industry.